US2020390820A1PendingUtilityA1
Isolation, cultivation and uses of stem/progenitor cells
Est. expiryAug 16, 2024(expired)· nominal 20-yr term from priority
C12N 5/0607C12N 5/0602A61P 1/18C12N 5/06C12N 5/00C12N 5/0629C12N 5/0662C12N 5/0668A61K 9/06A61P 25/14A61K 9/0014C12N 5/063C12N 5/0603C12N 5/0664A61P 17/02C12N 5/0667C12N 2506/025A61P 25/16A61P 25/28A61P 5/24C12N 5/0663A61K 35/36A61P 5/48A61P 3/10A61P 17/18A61P 7/06C12N 2506/1392C12N 5/0605A61P 17/16C12N 5/0666A61P 35/00A61K 35/28A61P 5/38C12N 5/0665C12N 5/0606A61P 17/00A61K 35/51A61P 5/14
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of cultivating mammalian cells. This method comprises cultivating the mammalian cells on a feeder layer, wherein the feeder layer comprises a stem/progenitor cell population isolated from the amniotic membrane of the umbilical cord
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method of cultivating mammalian cells comprising cultivating said mammalian cells on a feeder layer, wherein the feeder layer comprises a stem/progenitor cell population isolated from the amniotic membrane of the umbilical cord.
2 . The method of claim 1 , wherein the stem/progenitor cell population isolated from the amniotic membrane of the umbilical cord is an epithelial or mesenchymal stem/progenitor cell population that express the following genes: POU5f1, Bmi-1, leukemia inhibitory factor (LIF), and secrete Activin A and Follistatin.
3 . The method of claim 2 , wherein the epithelial or mesenchymal stem/progenitor cell population express the following growth factors: connective tissue growth factor (CTGF), vascular endothelial growth factor (VEGF), placenta-like growth factor PLGF, STAT3, stem cell factor (SCF), Hepatoma-derived Growth Factor (HDGF), Fibroblast Growth Factor-2 (FGF-2), Platelet-derived Growth Factor (PDGF), alpha-Smooth Muscle Actin (α-SMA), Fibronectin, Decorin, and Syndecan-1,2,3,4.
4 . The method of claim 1 , wherein the stem/progenitor cell population is isolated from the amniotic membrane of the umbilical cord by a method comprising:
(a) separating the amniotic membrane from the other components of the umbilical cord in vitro to obtain amniotic membrane tissue; (b) culturing the amniotic membrane tissue obtained in step (a) under conditions allowing cell proliferation; and (c) isolating the stem/progenitor cells, and wherein the stem/progenitor cells are epithelial or mesenchymal stem/progenitor cells.
5 . The method of claim 1 , wherein the feeder layer essentially consists of a stem/progenitor cell population isolated from the amniotic membrane of the umbilical cord.
6 . The method of claim 1 , wherein the stem/progenitor cell population isolated from the amniotic membrane of the umbilical cord is a human stem/progenitor cell population.
7 . The method of claim 1 , wherein the mammalian cells are stem cells.
8 . The method of claim 7 , wherein the stem cells are embryonic stem cells.
9 . The method of claim 1 , wherein the mammalian cells are cultured under serum free conditions.Join the waitlist — get patent alerts
Track US2020390820A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.